276 related articles for article (PubMed ID: 27150578)
1. Evolved resistance to colistin and its loss due to genetic reversion in Pseudomonas aeruginosa.
Lee JY; Park YK; Chung ES; Na IY; Ko KS
Sci Rep; 2016 May; 6():25543. PubMed ID: 27150578
[TBL] [Abstract][Full Text] [Related]
2. Genomic variations between colistin-susceptible and -resistant Pseudomonas aeruginosa clinical isolates and their effects on colistin resistance.
Lee JY; Na IY; Park YK; Ko KS
J Antimicrob Chemother; 2014 May; 69(5):1248-56. PubMed ID: 24474431
[TBL] [Abstract][Full Text] [Related]
3. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates.
Lee JY; Ko KS
Diagn Microbiol Infect Dis; 2014 Mar; 78(3):271-6. PubMed ID: 24412662
[TBL] [Abstract][Full Text] [Related]
4. Development of colistin resistance in pmrA-, phoP-, parR- and cprR-inactivated mutants of Pseudomonas aeruginosa.
Lee JY; Chung ES; Na IY; Kim H; Shin D; Ko KS
J Antimicrob Chemother; 2014 Nov; 69(11):2966-71. PubMed ID: 24994873
[TBL] [Abstract][Full Text] [Related]
5. Colistin resistance in Pseudomonas aeruginosa that is not linked to arnB.
Chung ES; Lee JY; Rhee JY; Ko KS
J Med Microbiol; 2017 Jun; 66(6):833-841. PubMed ID: 28621641
[TBL] [Abstract][Full Text] [Related]
6. Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria.
Lee JY; Choi MJ; Choi HJ; Ko KS
Antimicrob Agents Chemother; 2016 Jan; 60(1):609-12. PubMed ID: 26459897
[TBL] [Abstract][Full Text] [Related]
7. CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates.
Vila-Farrés X; Callarisa AE; Gu X; Savage PB; Giralt E; Vila J
Int J Antimicrob Agents; 2015 Nov; 46(5):568-71. PubMed ID: 26395218
[TBL] [Abstract][Full Text] [Related]
8. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.
Lora-Tamayo J; Murillo O; Bergen PJ; Nation RL; Poudyal A; Luo X; Yu HY; Ariza J; Li J
J Antimicrob Chemother; 2014 Sep; 69(9):2434-42. PubMed ID: 24833752
[TBL] [Abstract][Full Text] [Related]
9. In vitro efficacy of colistin against multi-drug resistant Pseudomonas aeruginosa by minimum inhibitory concentration.
Gill MM; Rao JU; Kaleem F; Hassan A; Khalid A; Anjum R
Pak J Pharm Sci; 2013 Jan; 26(1):7-10. PubMed ID: 23261721
[TBL] [Abstract][Full Text] [Related]
10. Rapid and Consistent Evolution of Colistin Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa during Morbidostat Culture.
Dößelmann B; Willmann M; Steglich M; Bunk B; Nübel U; Peter S; Neher RA
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630206
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
Mohanty S; Maurya V; Gaind R; Deb M
J Infect Dev Ctries; 2013 Nov; 7(11):880-7. PubMed ID: 24240048
[TBL] [Abstract][Full Text] [Related]
12. Emergence of colistin resistance in Pseudomonas aeruginosa ST235 clone in South Korea.
Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
Int J Antimicrob Agents; 2017 Jun; 49(6):767-769. PubMed ID: 28392440
[TBL] [Abstract][Full Text] [Related]
13. Aminoarabinosylation of Lipid A Is Critical for the Development of Colistin Resistance in Pseudomonas aeruginosa.
Lo Sciuto A; Imperi F
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263076
[TBL] [Abstract][Full Text] [Related]
14. Dynamic interaction of colistin and meropenem on a WT and a resistant strain of Pseudomonas aeruginosa as quantified in a PK/PD model.
Mohamed AF; Kristoffersson AN; Karvanen M; Nielsen EI; Cars O; Friberg LE
J Antimicrob Chemother; 2016 May; 71(5):1279-90. PubMed ID: 26850719
[TBL] [Abstract][Full Text] [Related]
15. Identification of nonclonal Pseudomonas aeruginosa isolates with reduced colistin susceptibility in Korea.
Lee JY; Song JH; Ko KS
Microb Drug Resist; 2011 Jun; 17(2):299-304. PubMed ID: 21381965
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of Pseudomonas aeruginosa isolates resistant to all antimicrobial agents, but susceptible to colistin, in Daegu, Korea.
Lee YC; Ahn BJ; Jin JS; Kim JU; Lee SH; Song DY; Lee WK; Lee JC
J Microbiol; 2007 Aug; 45(4):358-63. PubMed ID: 17846591
[TBL] [Abstract][Full Text] [Related]
18. Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment.
Valenza G; Radike K; Schoen C; Horn S; Oesterlein A; Frosch M; Abele-Horn M; Hebestreit H
Scand J Infect Dis; 2010 Dec; 42(11-12):885-9. PubMed ID: 20735333
[TBL] [Abstract][Full Text] [Related]
19. Adaptive and Mutational Responses to Peptide Dendrimer Antimicrobials in Pseudomonas aeruginosa.
Ben Jeddou F; Falconnet L; Luscher A; Siriwardena T; Reymond JL; van Delden C; Köhler T
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015046
[TBL] [Abstract][Full Text] [Related]
20. Loss of LPS is involved in the virulence and resistance to colistin of colistin-resistant Acinetobacter nosocomialis mutants selected in vitro.
Vila-Farrés X; Ferrer-Navarro M; Callarisa AE; Martí S; Espinal P; Gupta S; Rolain JM; Giralt E; Vila J
J Antimicrob Chemother; 2015 Nov; 70(11):2981-6. PubMed ID: 26311838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
